Lsk Polyclonal Antibody

The protein encoded by MATK has amino acid sequence similarity to Csk tyrosine kinase and has the structural features of the CSK subfamily: sRC homology SH2 and SH3 domains, a catalytic domain, a unique N terminus, lack of myristylation signals, lack of a negative regulatory phosphorylation site, and lack of an autophosphorylation site. This protein is thought to play a significant role in the signal transduction of hematopoietic cells. It is able to phosphorylate and inactivate Src family kinases, and may play an inhibitory role in the control of T-cell proliferation. This protein might be involved in signaling in some cases of breast cancer. Three alternatively spliced transcript variants that encode different isoforms have been described for this gene.

The Lsk Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of Lsk protein expression. This antibody has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The Lsk Polyclonal Antibody exhibits exceptional sensitivity and specificity, ensuring accurate and reproducible results. It recognizes the Lsk protein with high affinity, enabling the detection of even low levels of expression.

This antibody is produced using state-of-the-art techniques, ensuring batch-to-batch consistency and reliability. It has been rigorously tested to ensure minimal cross-reactivity with other proteins, guaranteeing the specificity of the detected signal.

The Lsk Polyclonal Antibody is supplied as a liquid formulation, making it easy to handle and use. It is provided in a convenient size, allowing for multiple experiments without the need for frequent reordering.

With its exceptional performance and reliability, the Lsk Polyclonal Antibody is an indispensable tool for researchers studying Lsk protein expression and its role in various biological processes.